Parents who are concerned about the heart risks of stimulants to treat attention deficit/hyperactivity disorder may hear conflicting advice from doctors, depending on whom they consult.
Last week, an advisory panel to the Food and Drug Administration voted 8-7 to suggest adding the agency’s strongest warning label to Ritalin, Adderall and similar medications. The panel based its decision on an FDA report that found 25 children and adults had died suddenly from 1999 to 2003 after taking ADHD drugs.
Steven Nissen, an advisory committee member, says many of the 4 million people who use the drugs may not realize that they have serious side effects. “I want parents and doctors, before they prescribe amphetamines and amphetamine-like drugs to children, to think a little harder whether they need them,” says Nissen, interim chairman of the Cleveland Clinic’s department of cardiovascular medicine.
(No Ratings Yet)
Loading ...This entry was posted on Friday, February 17th, 2006 at 10:39 am and is filed under General, Medications, Brain and Behavior, Disorders, ADHD and ADD, Treatment, Children & Teens. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.
Be a Part of the Conversation! Comment on this Entry Now:
